Bracey, Solomon
Ainsworth, Ben
Alderman, Joseph
Banerji, Christopher R. S.
Chakraborti, Tapabrata
Cresswell, Kathrin
Davies, Alisha
Hellon, Victoria
Harbron, Chris
Nash, Jonathan
Kostopoulou, Olga
Karoune, Emma
Wyatt, Jeremy C.
MacArthur, Ben D.
Fuggle, Nicholas
Article History
Received: 7 March 2025
Accepted: 31 March 2026
First Online: 30 April 2026
Declarations
Ethics approval and consent to participate: This study involved a multidisciplinary stakeholder workshop with expert discussions rather than a research study involving human participants where personal data is recorded. In line with guidance from the UK Health Research Authority, formal research ethics approval was therefore not required. Participation in the workshop and related discussions was entirely voluntary and was not a requirement of membership in the Clinical AI Interest Group. All contributors provided consent for their contributions to be used in the preparation of this manuscript and for their acknowledgement as contributors.
Consent for publication: All authors have consented to publication.
Competing interests: NF reports consultancy for DocHQ. CH is affiliated with Roche Pharmaceuticals. Authors affiliated with these organisations were involved with the design of the event and drafting of the manuscript.